25705176|t|Choroid plexus dysfunction impairs beta-amyloid clearance in a triple transgenic mouse model of Alzheimer's disease.
25705176|a|Compromised secretory function of choroid plexus (CP) and defective cerebrospinal fluid (CSF) production, along with accumulation of beta-amyloid (Abeta) peptides at the blood-CSF barrier (BCSFB), contribute to complications of Alzheimer's disease (AD). The AD triple transgenic mouse model (3xTg-AD) at 16 month-old mimics critical hallmarks of the human disease: beta-amyloid (Abeta) plaques and neurofibrillary tangles (NFT) with a temporal- and regional- specific profile. Currently, little is known about transport and metabolic responses by CP to the disrupted homeostasis of CNS Abeta in AD. This study analyzed the effects of highly-expressed AD-linked human transgenes (APP, PS1 and tau) on lateral ventricle CP function. Confocal imaging and immunohistochemistry revealed an increase only of Abeta42 isoform in epithelial cytosol and in stroma surrounding choroidal capillaries; this buildup may reflect insufficient clearance transport from CSF to blood. Still, there was increased expression, presumably compensatory, of the choroidal Abeta transporters: the low density lipoprotein receptor-related protein 1 (LRP1) and the receptor for advanced glycation end product (RAGE). A thickening of the epithelial basal membrane and greater collagen-IV deposition occurred around capillaries in CP, probably curtailing solute exchanges. Moreover, there was attenuated expression of epithelial aquaporin-1 and transthyretin (TTR) protein compared to Non-Tg mice. Collectively these findings indicate CP dysfunction hypothetically linked to increasing Abeta burden resulting in less efficient ion transport, concurrently with reduced production of CSF (less sink action on brain Abeta) and diminished secretion of TTR (less neuroprotection against cortical Abeta toxicity). The putative effects of a disabled CP-CSF system on CNS functions are discussed in the context of AD. 
25705176	0	26	Choroid plexus dysfunction	Disease	MESH:D020288
25705176	81	86	mouse	Species	10090
25705176	96	115	Alzheimer's disease	Disease	MESH:D000544
25705176	264	269	Abeta	Gene	11820
25705176	345	364	Alzheimer's disease	Disease	MESH:D000544
25705176	366	368	AD	Disease	MESH:D000544
25705176	375	377	AD	Disease	MESH:D000544
25705176	396	401	mouse	Species	10090
25705176	414	416	AD	Disease	MESH:D000544
25705176	467	472	human	Species	9606
25705176	496	501	Abeta	Gene	351
25705176	515	538	neurofibrillary tangles	Disease	MESH:D055956
25705176	540	543	NFT	Disease	MESH:D055956
25705176	703	708	Abeta	Gene	351
25705176	712	714	AD	Disease	MESH:D000544
25705176	768	770	AD	Disease	MESH:D000544
25705176	778	783	human	Species	9606
25705176	801	804	PS1	Gene	5663
25705176	809	812	tau	Gene	4137
25705176	1164	1169	Abeta	Gene	351
25705176	1188	1238	low density lipoprotein receptor-related protein 1	Gene	4035
25705176	1240	1244	LRP1	Gene	4035
25705176	1254	1297	receptor for advanced glycation end product	Gene	177
25705176	1299	1303	RAGE	Gene	177
25705176	1516	1527	aquaporin-1	Gene	11826
25705176	1532	1545	transthyretin	Gene	22139
25705176	1547	1550	TTR	Gene	22139
25705176	1579	1583	mice	Species	10090
25705176	1622	1636	CP dysfunction	Disease	MESH:D020288
25705176	1673	1678	Abeta	Gene	11820
25705176	1800	1805	Abeta	Gene	11820
25705176	1835	1838	TTR	Gene	22139
25705176	1878	1883	Abeta	Gene	11820
25705176	1884	1892	toxicity	Disease	MESH:D064420
25705176	1993	1995	AD	Disease	MESH:D000544
25705176	Association	MESH:D000544	351
25705176	Association	MESH:D064420	22139
25705176	Association	177	351
25705176	Association	MESH:D000544	4137
25705176	Association	MESH:D020288	22139
25705176	Association	351	4035
25705176	Association	MESH:D000544	11820
25705176	Positive_Correlation	MESH:D020288	11820
25705176	Association	MESH:D000544	5663

